Estradiol Completed Phase 4 Trials for Osteoporosis / one to five years postmenopausal Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00185328Efficacy and Tolerability of Angeliq in Thai Women
NCT00294463Effects of Tibolone Treatment on the Endometrium
NCT00701337Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route